EU Pharma Reform: Negotiations Could See Patient Voice ‘Discarded,’ Warn Patient Groups

 
• By Eliza Slawther
  
Plans to include patients in EMA committees could be scrapped under the new pharma legislation reform, patient groups say (Shutterstock)

More from EU Pharma Legislation Reform

More from Pathways & Standards